PROHEPCIDIN AND RESISTANCE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN CHRONIC KIDNEY DISEASE PATIENTS ON HEMODIALYSIS

• Type: Summary of Presentation in an International Conference
• Date: 2008

Authors

Elísio Costa (Author) Other; Brian J.G. Pereira (Author) Other; Petronila Rocha-Pereira (Author) Other; Susana Rocha (Author) FFUP; Flávio Reis (Author) Other; Eleisabeth Castro (Author) FFUP; Frederico Teixeira (Author) Other; Vasco Miranda (Author) Other; Maria do Sameiro Faria (Author) Other; Alfredo Loureiro (Author) Other; Alexandre Quintanilha (Author) Other; Luis Belo (Author) FFUP; Alice Santos-Silva (Author) FFUP

Conference proceedings International

Title: Portuguese Journal of Nephrology and Hypertension

Pages: ii154-ii155

23rd Congress of the Portuguese Society of Nephrology

Indexing

Pubmed / Medline

Scientific classification

FOS: Medical and Health sciences > Other medical sciences

CORDIS: Health sciences

Other information

Resumo (PT): Our data show that a close interaction exists between inflammation, iron status and prohepcidin serum levels that ultimately regulate intracellular iron availability. Prohepcidin and s-TfR, together with CRP, were found to be good markers of resistance to rhEPO therapy in HD patients. <br> <br> <a target="_blank" href="http://ndtplus.oxfordjournals.org/cgi/reprint/1/suppl_2/ii26"> Texto integral</a> <br> <br>

Abstract (EN): Our data show that a close interaction exists between inflammation, iron status and prohepcidin serum levels that ultimately regulate intracellular iron availability. Prohepcidin and s-TfR, together with CRP, were found to be good markers of resistance to rhEPO therapy in HD patients. <br> <br> <a target="_blank" href="http://ndtplus.oxfordjournals.org/cgi/reprint/1/suppl_2/ii26"> Full text </a> <br> <br>

Language: English

Type (Professor's evaluation): Scientific